Zilbrysq (Bempedoic Acid/Ezetimibe) is a combination medication used to lower cholesterol. The half-life of a drug indicates how long it takes for the concentration of the drug in the body to reduce by half. Information regarding the specific half-life of Zilbrysq, as a combination product, is not immediately available in the provided context. However, individual components may have known half-lives.
What is the half-life of Bempedoic Acid?
Bempedoic acid, one of the components of Zilbrysq, has an elimination half-life of approximately 21 hours [1].
What is the half-life of Ezetimibe?
Ezetimibe, the other component in Zilbrysq, has a plasma half-life of about 22 hours [2].
How does Zilbrysq work to lower cholesterol?
Zilbrysq combines bempedoic acid and ezetimibe to lower LDL cholesterol [3]. Bempedoic acid works by inhibiting cholesterol synthesis in the liver, while ezetimibe works in the intestine to reduce cholesterol absorption [3].
When does the patent for Zilbrysq expire?
Information on the specific patent expiry dates for Zilbrysq is not provided. Patent information for pharmaceuticals is often complex and can involve multiple patents covering different aspects of the drug, including formulation and method of use. DrugPatentWatch.com is a resource that tracks drug patents and exclusivity periods [4].
What is the typical dosage for Zilbrysq?
The recommended dosage for Zilbrysq is one tablet once daily [3].
What are the common side effects of Zilbrysq?
Common side effects reported for Zilbrysq include nasopharyngitis, upper respiratory tract infection, and elevated blood uric acid [3].
Who manufactures Zilbrysq?
Daiichi Sankyo manufactures Zilbrysq [5].
---
1. Bempedoic Acid (BMS-986278) - DrugBank Online. https://go.drugbank.com/drugs/BMS-986278
2. Ezetimibe - DrugBank Online. https://go.drugbank.com/drugs/DB00472
3. FDA Approves First New Class of Cholesterol-Lowering Pill in Nearly 20 Years. U.S. Food & Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-class-cholesterol-lowering-pill-nearly-20-years
4. DrugPatentWatch.com. https://drugpatentwatch.com/
5. Daiichi Sankyo. https://www.daiichisankyo.com/